Literature DB >> 9921752

Prognostic value of histopathological grading in canine extramedullary plasmacytomas.

S J Platz1, W Breuer, S Pfleghaar, G Minkus, W Hermanns.   

Abstract

The canine extramedullary plasmacytoma (cEMP) has recently been the subject of numerous investigations, indicating that the histomorphologic diagnosis is often difficult because of the variety of morphologic features. Therefore, the objective of this study was to establish a subclassification scheme for cEMPs and to evaluate correlations between the types and malignancy. Retrospectively, 117 cEMPs, all immunohistochemically characterized by a monoclonal immunoglobulin light-chain expression, were collected and assigned to morphologic types. These types were compared using data from a follow-up study on metastasis and tumor recurrence, then compared by proliferation rate, determined by immunohistochemical detection of the antigen Ki-67. Histopathologic typing revealed five different types of cEMPs, ranging from the mature type with typical plasma cells to the polymorphous-blastic type. Between these two forms, three additional types were established: hyaline, cleaved, and asynchronous. Most of the cEMPs were of the cleaved and asynchronous types. In all cEMPs, mononuclear and multinuclear giant cells were present to varying degrees. Although the results of cell proliferation and the follow-up study indicated less benign behavior by the polymorphous-blastic type, the proliferation rate revealed no statistically significant differences among the cEMP types. The clinical data therefore confirmed previous findings that the risk of tumor recurrence and metastasis in general can be classed as low. The established cEMP typing system is probably a very helpful diagnostic tool, although the types cannot be used for a tumor grading system.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9921752     DOI: 10.1354/vp.36-1-23

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  9 in total

1.  Extramedullary plasmacytoma in the lung of a Doberman pinscher dog.

Authors:  Lauren Adelman; Victoria Larson; Thomas Sissener; Tim Spotswood
Journal:  Can Vet J       Date:  2014-01       Impact factor: 1.008

2.  Chromogenic in situ hybridization for the detection of lambda and kappa immunoglobulin light chains as a potential auxiliary diagnostic technique in canine plasmacytomas.

Authors:  Greta Foiani; Claudia Zanardello; Antonio Carminato; Erica Melchiotti; Paola Roccabianca; Marco Tecilla; Marta Vascellari
Journal:  J Vet Diagn Invest       Date:  2020-07-05       Impact factor: 1.279

3.  Intravascular neoplastic cells in canine cutaneous plasmacytomas.

Authors:  Gordon Ehrensing; Linden E Craig
Journal:  J Vet Diagn Invest       Date:  2018-01-02       Impact factor: 1.279

Review 4.  Review of diagnostic histologic features of cutaneous round cell neoplasms in dogs.

Authors:  Daniel R Rissi; Fabiano N Oliveira
Journal:  J Vet Diagn Invest       Date:  2022-06-02       Impact factor: 1.569

5.  Surgery and radiation therapy for extramedullary plasmacytoma of the penile mucosa in a dog.

Authors:  Jackie M Wypij; Louis-Philippe de Lorimier
Journal:  Can Vet J       Date:  2012-09       Impact factor: 1.008

6.  Immunoglobulin A multiple myeloma with cutaneous involvement in a dog.

Authors:  Monique N Mayer; Moira E Kerr; Candace K Grier; Valerie S Macdonald
Journal:  Can Vet J       Date:  2008-07       Impact factor: 1.008

7.  Tonsillar plasmacytoma in a dog.

Authors:  Yoshimi Iwaki; Colleen Monahan; Rebecca Smedley; David Upchurch; Paulo Vilar-Saavedra
Journal:  Can Vet J       Date:  2018-08       Impact factor: 1.008

8.  Feline Respiratory Extramedullary Plasmacytoma with Lymph Node Metastasis and Intrahistiocytic Amyloid.

Authors:  S E Sykes; V Byfield; L Sullivan; S J Bender; P F Moore; M D Sánchez
Journal:  J Comp Pathol       Date:  2016-12-22       Impact factor: 1.311

9.  Oral Plasmacytoma in a Dog.

Authors:  Indira Pargass; Alissa Bally; Rod Suepaul
Journal:  Vet Sci       Date:  2017-12-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.